HuGE Literature Finder
Records
1
-
4
Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings? Pharmacogenomics 2017 May . Taranu Adela, Colle Romain, Gressier Florence, El Asmar Khalil, Becquemont Laurent, Corruble Emmanuelle, Verstuyft Céli |
Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population. European journal of clinical pharmacology 2016 Apr . Jose Manu, Mathaiyan Jayanthi, Kattimani Shivanand, Adithan Surendiran, Chandrasekaran Adith |
Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. International journal of clinical pharmacy 2016 Jan . Yuce-Artun Nazan, Baskak Bora, Ozel-Kizil Erguvan Tugba, Ozdemir Hatice, Uckun Zuhal, Devrimci-Ozguven Halise, Suzen Halit Sin |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: